Emboline v AorticLab (CFI, 16 April 2025)
| Date | 16 April 2025 |
|---|---|
| Court | CFI |
| Division | Munich (DE) Local Division |
| Type of action | Generic application |
| Registry reference | App_8962/2025 · ORD_9097/2025 |
| Parties | Emboline, Inc. |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By order of 16 April 2025 (UPC_CFI_628/2024, App_8962/2025), Judge-rapporteur Pichlmaier of the Munich Local Division ordered AorticLab, defendant to Emboline’s infringement action on EP 2 129 425 and counterclaimant for revocation, to provide security of EUR 200,000 for Emboline’s costs. The deadline is two weeks after service of any Court of Appeal decision upholding the order, or 31 May 2025 if no appeal is lodged. Leave to appeal was granted. The order accepts that an infringement claimant may obtain security in its capacity as defendant to the counterclaim.
Question
May the infringement claimant, as defendant to the counterclaim for revocation, obtain security for costs under Art. 69(4) UPCA, and does the defendant’s own statement that it fears insolvency justify it?
Decision
The judge left open whether the Düsseldorf practice, under which each party may request security, is consistent with Art. 69(4), which refers to a request « of the defendant ». In any event, Emboline is also a defendant: under the UPCA a claimant is also whoever brings a revocation action or a counterclaim for revocation (Art. 32(1)(d) and (e)), and Art. 33(8) calls the counterclaimant the applicant. Under the Court of Appeal’s test, AorticLab’s own statement that an injunction would drive it into insolvency gives rise to a legitimate and real concern that a costs order may not be recoverable, since the costs order would follow the injunction. The amount reflects the recoverable costs for a counterclaim value of up to EUR 2 million.
Key points for practice
- Practical point: a party’s own statement about its financial fragility in the face of an injunction may be turned against it in support of an application for security for costs.
Provisions applied
- Agreement on a Unified Patent Court
- Arts 32(1)(a), (d) and (e), 33(8) and 69(4)
- Rules of Procedure
- Rules 158, 220.2 and 355
- Case law cited
- Court of Appeal, UPC_CoA_217/2024
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Written procedure (UPC), Court fees and costs (UPC).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimantEmboline, Inc.7 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Generic application
- Outcome (Dhenne Avocats summary)
- AorticLab doit constituer une garantie de 200 000 EUR pour les frais d'Emboline, défenderesse à la demande reconventionnelle. L'autorisation d'appel est accordée.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 2 129 425mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- AorticLab v Emboline (CoA, 20 June 2025) cites this decision
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 2 129 425 | Mentioned in the analysis (role not qualified) Also mentioned in 5 other decision(s): AorticLab v Emboline (CoA, 17 August 2026) · Emboline v AorticLab (CoA, 16 July 2026) · Emboline v AorticLab (CFI, 13 January 2026) · AorticLab v Emboline (CoA, 20 June 2025) · Emboline v AorticLab (CoA, 28 September 2026) | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.